LEADER 01481nam  2200397 a 450 
001 9910700359103321
005 20110510142428.0
035   $a(CKB)5470000002409395
035   $a(OCoLC)721978165
035   $a(EXLCZ)995470000002409395
100   $a20110510d2010      ua         0
101 0 $aeng
135   $aurmn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aMedicaid outpatient prescription drugs$b[electronic resource] $eestimated changes in federal upper limits using the formula under the Patient Protection and Affordable Care Act /$f[John E. Dicken]
210  1$aWashington, DC :$cU.S. Govt. Accountability Office,$d[2010]
215   $a1 online resource (13 pages) $cillustrations
300   $aTitle from PDF caption title screen (GAO, viewed May 4, 2011).
300   $a"December 15, 2010."
300   $a"GAO-11-141R."
320   $aIncludes bibliographical references.
517   $aMedicaid outpatient prescription drugs 
606   $aMedicaid
606   $aPharmaceutical services insurance$xEconomic aspects$zUnited States
615  0$aMedicaid.
615  0$aPharmaceutical services insurance$xEconomic aspects
700   $aDicken$b John E$01382684
712 02$aUnited States.$bGovernment Accountability Office.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910700359103321
996   $aMedicaid outpatient prescription drugs$93446157
997   $aUNINA